These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8185689)

  • 1. Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial.
    Kloppenburg M; Breedveld FC; Terwiel JP; Mallee C; Dijkmans BA
    Arthritis Rheum; 1994 May; 37(5):629-36. PubMed ID: 8185689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.
    Tilley BC; Alarcón GS; Heyse SP; Trentham DE; Neuner R; Kaplan DA; Clegg DO; Leisen JC; Buckley L; Cooper SM; Duncan H; Pillemer SR; Tuttleman M; Fowler SE
    Ann Intern Med; 1995 Jan; 122(2):81-9. PubMed ID: 7993000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled trial.
    O'Dell JR; Haire CE; Palmer W; Drymalski W; Wees S; Blakely K; Churchill M; Eckhoff PJ; Weaver A; Doud D; Erikson N; Dietz F; Olson R; Maloley P; Klassen LW; Moore GF
    Arthritis Rheum; 1997 May; 40(5):842-8. PubMed ID: 9153544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits and risks of minocycline in rheumatoid arthritis.
    Langevitz P; Livneh A; Bank I; Pras M
    Drug Saf; 2000 May; 22(5):405-14. PubMed ID: 10830256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of early seropositive rheumatoid arthritis with minocycline: four-year followup of a double-blind, placebo-controlled trial.
    O'Dell JR; Paulsen G; Haire CE; Blakely K; Palmer W; Wees S; Eckhoff PJ; Klassen LW; Churchill M; Doud D; Weaver A; Moore GF
    Arthritis Rheum; 1999 Aug; 42(8):1691-5. PubMed ID: 10446869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minocycline in the treatment of rheumatoid arthritis: relationship of serum concentrations to efficacy.
    Kloppenburg M; Mattie H; Douwes N; Dijkmans BA; Breedveld FC
    J Rheumatol; 1995 Apr; 22(4):611-6. PubMed ID: 7791150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study.
    Aletaha D; Bingham CO; Tanaka Y; Agarwal P; Kurrasch R; Tak PP; Popik S
    Lancet; 2017 Mar; 389(10075):1206-1217. PubMed ID: 28215362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
    Ogrendik M
    Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: a 1-week, randomized, double-blind, placebo-controlled trial.
    Lee EY; Lee EB; Park BJ; Lee CK; Yoo B; Lim MK; Shim SC; Sheen DH; Seo YI; Kim HA; Baek HJ; Song YW
    Clin Ther; 2006 Dec; 28(12):2052-60. PubMed ID: 17296461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minocycline treatment for rheumatoid arthritis: an open dose finding study.
    Breedveld FC; Dijkmans BA; Mattie H
    J Rheumatol; 1990 Jan; 17(1):43-6. PubMed ID: 2313671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results from a Phase IIA Parallel Group Study of JNJ-40346527, an Oral CSF-1R Inhibitor, in Patients with Active Rheumatoid Arthritis despite Disease-modifying Antirheumatic Drug Therapy.
    Genovese MC; Hsia E; Belkowski SM; Chien C; Masterson T; Thurmond RL; Manthey CL; Yan XD; Ge T; Franks C; Greenspan A
    J Rheumatol; 2015 Oct; 42(10):1752-60. PubMed ID: 26233509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An evaluation of efficacy of minocycline as an anti-rheumatic drug in patients with active and refractory rheumatoid arthritis].
    Kawanaka N; Yamamura M; Hashimoto H; Okamoto H; Morita Y; Kawashima M; Aita T; Okamoto A; Makino H
    Ryumachi; 1998 Dec; 38(6):801-9. PubMed ID: 10047718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minocycline for rheumatoid arthritis.
    Kim NM; Freeman CD
    Ann Pharmacother; 1995 Feb; 29(2):186-7. PubMed ID: 7756719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minocycline in active rheumatoid arthritis. A placebo-controlled trial.
    Kloppenburg M; Terwiel JP; Mallée C; Breedveld FC; Dijkmans BA
    Ann N Y Acad Sci; 1994 Sep; 732():422-3. PubMed ID: 7978827
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibiotics as disease modifiers in arthritis.
    Kloppenburg M; Breedveld FC; Miltenburg AM; Dijkmans BA
    Clin Exp Rheumatol; 1993; 11 Suppl 8():S113-5. PubMed ID: 8324934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
    Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK
    J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adalimumab plus methotrexate for the treatment of rheumatoid arthritis: a multi-center randomized, double-blind, placebo-controlled clinical study.].
    Huang F; Zhang FC; Bao CD; Tao Y; Gu JR; Xu JH; Zhu P; Xu HJ; Zhang ZY; Zhao DB; Wu DH
    Zhonghua Nei Ke Za Zhi; 2009 Nov; 48(11):916-21. PubMed ID: 20079321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.
    Smolen JS; Kay J; Doyle MK; Landewé R; Matteson EL; Wollenhaupt J; Gaylis N; Murphy FT; Neal JS; Zhou Y; Visvanathan S; Hsia EC; Rahman MU;
    Lancet; 2009 Jul; 374(9685):210-21. PubMed ID: 19560810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory and immunological parameters of disease activity in rheumatoid arthritis patients treated with minocycline.
    Kloppenburg M; Dijkmans BA; Verweij CL; Breedveld FC
    Immunopharmacology; 1996 Mar; 31(2-3):163-9. PubMed ID: 8861742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial.
    van Everdingen AA; Jacobs JW; Siewertsz Van Reesema DR; Bijlsma JW
    Ann Intern Med; 2002 Jan; 136(1):1-12. PubMed ID: 11777359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.